Cardiac Rehabilitation

Definition

Cardiac rehabilitation (CR) is a medically supervised, multidisciplinary secondary prevention program for patients with cardiovascular disease. Defined by the US Social Security Act, CR requires a physician medical director, day-to-day physician or nonphysician practitioner supervision, and all core therapeutic components delivered via individualized treatment plans updated every 30 days. CR reduces mortality and improves quality of life across qualifying CVD diagnoses, but remains massively underutilised (~20% national enrollment; target 70%). The AHA/AACVPR 2024 Scientific Statement is the definitive framework, updated for the first time since 2007. (sources/cardiac-rehab-aha-2024, rating: very high)

Epidemiology

• Only ~24% of eligible US patients participated in CR in 2020 — one of the largest quality gaps in cardiovascular medicine sources/crp-nejm-2024 (high)
• Only 24% enrolled within 21 days of qualifying event; only 27% completed the full 36-session course
• Estimated program capacity sufficient for only 37% of eligible patients nationally
• Disparities by subgroup: women 18.9%; age >85 → 9.8%; non-Hispanic Black 13.6%; Hispanic 13.2%; dual Medicare-Medicaid 6.9%; geographic variability 20–39%
• Trends (1997→2020): CABG 31%→55%; post-MI with PCI 21%→33%; post-MI without revascularization fell 11%→7%
• Automatic referral systems + patient navigators boost participation from 30% to 74%; financial incentives (Medicaid) double completion rate; removing cost-sharing adds ~6 sessions (theoretical 6–12% mortality reduction) sources/crp-nejm-2024 (high)
• Participation drops 1% for every 1-day delay in enrollment; ideally begin within 1–2 weeks post-event sources/crp-nejm-2024 (high)
• 67% greater exercise capacity improvement when enrolled within 15 days vs ≥30 days post-discharge

Indications

Medicare-defined qualifying diagnoses:

• Acute MI within past 12 months
• Coronary artery bypass graft (CABG) surgery
• Coronary angioplasty or stenting
• Heart valve repair or replacement
• Heart or heart–lung transplantation
• Stable angina
• Stable chronic heart failure: LVEF ≤35% + NYHA Class II–IV symptoms despite optimal HF therapy ≥6 weeks (sources/cardiac-rehab-aha-2024, rating: very high)

Program Structure

The four-phase model is the standard European/international CR structure, with timing tied to the stage of recovery from acute MI. sources/crp-jcm-2025 (medium)

• Phase I — In-hospital (acute stage):

  • Initiated during hospitalisation; tailored to individual clinical and functional assessment
  • Begins with sitting up in bed, upper/lower extremity function tests, then progresses to short walks
  • Goals: educate patient on CV risk factors and exercise benefits, reduce bed-rest complications, provide psychosocial support
  • Evidence: exercise starting 3–7 days post-PCI reduces cardiac remodeling and increases LVEF (Zheng 2008 RCT); early rehabilitation within 3 days reduces hospital stay (Nakamura 2021); Phase I reduces revascularisation risk −20% and readmissions −19% over ~1 year in a dose-dependent manner (Kanazawa 2020)

• Phase II — Post-discharge (6–12 weeks Europe; 6–36 visits US):

  • Begins ideally 1–4 weeks post-discharge; continues supervised exercise with risk factor control
  • Exercise prescription (FITT-VP framework): aerobic (cycling, jogging — improves HTN, insulin resistance, obesity) + strength training (weightlifting — improves glucose metabolism, body composition, basal metabolic rate)
  • Illness perception is a key determinant of Phase II adherence: patients who understand their condition sustain higher long-term motivation; BIPQ score improves early in Phase II then may decline as awareness of disease chronicity raises emotional concerns (Darsin Singh 2023, n=450)
  • 3-month post-discharge exercise programme + 9-month community-based self-management → lower MACE, better LVEF and 6MWT vs medical therapy alone (Xiao 2021 RCT, n=164)

• Phase III — Long-term outpatient (less supervision):

  • Maintains lifestyle changes from Phase II with reduced professional supervision
  • Evidence is sparse and inconsistent: 8-week Phase III had no effect on non-fatal MI or HF hospitalisation at 5.6 years (Brawner 2017, n=230 retrospective); 3-year multifactorial educational programme did reduce cardiac events (GOSPEL study 2008 RCT, n=3,241)

• Phase IV — Maintenance (indefinite):

  • For patients completing Phases I–III; focus on sustaining heart-healthy lifestyle long term
  • Paucity of literature; patients commonly revert to unhealthy habits after programme completion

Core Components

Nine core components per the 2024 AHA/AACVPR framework:

1. Patient assessment — comprehensive medical, functional, social, and home environment evaluation; ITP at entry; final outcomes report at completion
2. Nutritional counseling — validated food frequency questionnaire; DASH/Mediterranean/plant-based patterns; SMART goal setting; dietitian referral criteria
3. Weight management and body composition — body fat:lean ratio as primary target; waist circumference most feasible; HIIT superior for body composition improvement
4. CVD and risk factor management:
   • HTN: SBP <130 / DBP <80 mmHg
   • Dyslipidemia: LDL-C <70 mg/dL (ASCVD), <55 mg/dL (very high risk)
   • Diabetes: HbA1c <7% for most patients
   • Tobacco: cessation intervention for all current/recent smokers
5. Psychosocial management — validated screening (depression, stress, anxiety, loneliness, substance use); CBT and stress management techniques; persisting depression at completion predicts increased post-CR mortality
6. Aerobic exercise training — 3–5 days/week; moderate (40–59% HRR) to vigorous (60–89% HRR); 20–60 min/session; FITT-based progression; HIIT safe and superior for cardiorespiratory fitness (CRF) improvement
7. Strength training (new standalone component, 2024) — 2–3 non-consecutive days/week; 40–60% 1-RM; 8–10 exercises; 10–15 reps/set; frailty and fall prevention
8. Physical activity counseling — ≥150 min/week moderate or ≥75 min vigorous; step count monitoring; minimise sedentary time
9. Program quality (new core component, 2024) — annual assessment at system/program/patient levels; equity focus; target 70% enrollment (sources/cardiac-rehab-aha-2024, rating: very high)

Exercise Prescription

Aerobic

• Frequency: 3–5 days/week (3 supervised + home exercise on non-CR days aiming for ≥5 total)
• Intensity — Moderate: 40–59% HRR; RPE 12–13 on Borg 6–20 scale
• Intensity — Vigorous: 60–89% HRR; RPE 14–17; do NOT use resting HR + 20–30 bpm or age-predicted max HR — wide inaccuracy at the individual level
• Safety ceiling: Reduce target by 10 bpm below HR at: angina, SBP >240 mmHg, ST depression >1 mm, AF onset, SVT, complex ventricular ectopy, or other exertional intolerance
• Duration: 20–60 min per session; advance duration by 1–5 min/session first, then increase intensity (5–10% increments)
• Modes: treadmill, cycling, elliptical, rowing, stair climbing, arm/leg ergometry; HIIT is safe in CR and outperforms MICT for VO2 max improvement
• Goals: ≥15% increase in peak VO2; ≥40% increase in estimated peak MET; ≥10% increase in 6-min walk distance (sources/cardiac-rehab-aha-2024, rating: very high)

Strength Training

• Frequency: 2–3 non-consecutive days/week
• Intensity: 40–60% of 1-repetition maximum; RPE 11–13; increase load by ~5% (upper body) or 10–20% (lower body) when upper rep limit achieved comfortably
• Volume: 1–3 sets × 8–10 exercises targeting major muscle groups × 10–15 reps/set; advance to 3 sets as tolerated
• Equipment: weight machines, free weights, elastic bands, body weight — all appropriate; multijoint exercises (row, chest press) prioritised when session time is limited
• Breathing: exhale on contraction, inhale on relaxation — critical safety instruction for remote delivery
• Goal: Prevent/treat frailty and reduce fall risk; also improves lean mass and CRF in low-functioning individuals
• Frailty/fall assessment tools at CR entry: Timed Up and Go (≥12 s = fall risk); 30-Second Chair Stand (age/sex norms); 4-Stage Balance Test; Berg Balance Scale (41–56 independent; 21–40 walking assistance; 0–20 wheelchair-bound) (sources/cardiac-rehab-aha-2024, rating: very high)

Delivery Models

• In-person: Traditional hospital or physician office setting
• Virtual (synchronous): Real-time audiovisual interaction throughout session; CR clinicians interact with patients for the full session
• Remote (asynchronous): No real-time interaction; wearables, activity monitors, and digital platforms relay data to the CR team
• Hybrid: Variable combination of delivery modes tailored to patient needs — likely the key strategy to close the enrollment gap
• Evidence: virtual and remote CR have similar efficacy and safety to in-person CR for low–moderate risk patients in improving CVD risk factors, mortality risk, and health-related QoL
• Any alternative delivery model that lacks physician oversight and full core components is not CR and is not an acceptable substitute (sources/cardiac-rehab-aha-2024, rating: very high)

Special Populations

Elderly and Frail Patients (PIpELINe Trial)

• Traditional CR programs were designed for younger post-surgical patients; older/frail patients have lower participation, earlier withdrawal, and less benefit from conventional intensive programs
• After age 70, aerobic capacity declines >20% per decade; median age in home-based CR studies ~68 years — far below the elderly post-MI population
• PIpELINe trial (NEJM 2025, n=512, median age 80): multicenter Italian RCT; 12-month multidomain intervention (CV risk factor management + dietary counseling + exercise training) vs. usual care in patients ≥65 with impaired physical performance (SPPB 4–9) at 1 month post-MI; 2:1 allocation (sources/pipeline-mi-nejm-2025, rating: very high)
  • Primary outcome (CV death or unplanned CV hospitalization at 1 year): HR 0.57 (95% CI 0.36–0.89, P=0.01); NNT ≈12.5
  • HF hospitalization: HR 0.20 (95% CI 0.07–0.56) — most striking benefit
  • CV death: HR 0.69 (NS); unplanned CV hospitalization: HR 0.48
  • Physical performance and QoL (SPPB, gait speed, grip strength, EQ-5D-5L) improved at 6 months and 1 year
  • No serious adverse events; compliance 71%; benefit consistent across diabetes, CKD, LVEF ≤40%, prefrail, and NSTEMI subgroups
• Exercise design for elderly/frail patients (Otago Program): balance exercises + upper/lower-limb functional strength exercises; ≥20 min moderate walking ≥4×/week; 6 on-site supervised individual sessions over 12 months + individualized home-based prescription between sessions; intensity individualized from 1-km treadmill test; progression per session
• Patient selection principle: SPPB 4–9 identifies those neither too fit (limited benefit ceiling) nor too compromised (intervention may be futile) — the actionable rehabilitation zone
• Goals of care for older adults extend beyond survival: well-being, functional independence, autonomy, and quality relationships are independently important targets; HF hospitalization reduction carries substantial socioeconomic value (sources/pipeline-mi-nejm-2025, rating: very high)

Program Quality

• National CR enrollment: ~20% of eligible patients; Million Hearts CR Collaborative target: 70%
• Quality assessment levels: system (hospital referral rates), program (enrollment/adherence/completion rates), patient (fitness, risk factor, psychosocial outcomes)
• AACVPR patient-level performance measures: functional capacity improvement, depression, BP control, tobacco intervention — submitted with triennial AACVPR program certification
• Populations at systematic risk for CR underenrollment: women, racial/ethnic minorities, rural patients, elderly, frail, non-English speakers, low socioeconomic status
• Hybrid programming is the principal proposed strategy to increase access and close the enrollment gap (sources/cardiac-rehab-aha-2024, rating: very high)
• Prompt referral, ideally using automatic referral systems at hospital discharge, is essential

Contradictions / Open Questions

• Mortality benefit: RCT vs observational data discrepancy: Cochrane systematic review of CR RCTs shows little or no effect on all-cause mortality; large observational studies (SWEDEHEART; Medicare post-PCI) show clear 1–2% mortality reduction per session attended. This discrepancy may reflect improvement in usual care over time, quality issues in older RCTs, or healthy-participant bias in observational data. sources/crp-nejm-2024 (high)
• Remote psychosocial delivery evidence gap: Evidence is mixed on whether phone/internet-based psychosocial interventions achieve outcomes equivalent to face-to-face CR; RCT evidence is limited, especially for diverse and underserved populations; supportive environment and peer interaction may be harder to replicate remotely
• Body composition assessment across diverse populations: Waist circumference and bioelectrical impedance cutoffs have not been validated across racial/ethnic subgroups; DEXA cutoffs for adiposity and sarcopenia may differ by ancestry
• HIIT in high-risk CR patients: HIIT is safe and effective for low–moderate risk CR patients; evidence in very high-risk patients (recent ACS, advanced HF, complex arrhythmia, severe frailty) is limited — individualization required. PIpELINe (NEJM 2025) used low-to-moderate intensity walking and Otago-style exercises (not HIIT) in patients with median age 80 and SPPB 4–9 — providing the first RCT evidence that a low-intensity, session-limited program achieves clinically meaningful outcomes in this population (sources/pipeline-mi-nejm-2025, rating: very high)
• Frailty threshold for rehabilitation: PIpELINe paradoxically showed stronger benefit in prefrail (HR 0.48) than in frail patients (HR 0.87), and no benefit in the PAD subgroup (HR 1.06); the optimal SPPB or frailty phenotype threshold to identify who benefits most remains unresolved; those with very advanced frailty or co-morbidity limiting mobility may not derive the same benefit (sources/pipeline-mi-nejm-2025, rating: very high)
• Long-term virtual/remote CR efficacy: Short-term equivalence is established; long-term outcome data and safety in underserved communities with technologic and environmental barriers are unproven
• mHealth CR fails in older adults (RESILIENT RCT): Mobile health-based CR did not improve 6-minute walk distance, health status, or daily activities in older adults with ischemic heart disease vs standard care — directly contradicts the assumption that digital delivery models translate across age groups; age-specific adaptations to mHealth CR strategies are required before deployment in older populations. sources/crp-jcm-2025 (medium)

Connections

• Related to entities/Heart-Failure — stable HF (LVEF ≤35%, NYHA II–IV) is a Medicare-qualifying CR indication; CR reduces mortality in HF
• Related to concepts/Dyslipidemia-Management — CR LDL-C targets (<70/<55 mg/dL) identical to secondary prevention guideline goals
• Related to concepts/ASCVD-Risk-Assessment — CR is the structured clinical implementation of secondary prevention following an ASCVD event
• Related to concepts/Exercise-in-HCM — CR FITT framework provides the foundational aerobic/strength prescription model for HCM post-procedure rehabilitation
• Related to entities/Atrial-Fibrillation — AF is a criterion for exercise intensity ceiling adjustment during CR
• Related to concepts/Heart-Healthy-Dietary-Patterns — CR nutritional counseling goals align with AHA 2026 heart-healthy dietary patterns
• Related to entities/Frailty-in-Cardiovascular-Disease — frailty and SPPB as rehabilitation targets; PIpELINe as the key RCT for elderly/frail post-MI patients
• Related to entities/Acute-Coronary-Syndrome — post-MI rehabilitation as Class I secondary prevention; multidomain approach for elderly post-MI (PIpELINe)
• Related to sources/cardiac-rehab-aha-2024
• Related to sources/pipeline-mi-nejm-2025
• Related to sources/crp-nejm-2024

Sources

• sources/cardiac-rehab-aha-2024
• sources/pipeline-mi-nejm-2025
• sources/crp-nejm-2024 — 2024 NEJM review by Thomas RJ; participation gap statistics, historical perspective, home-based CR evidence, NNT data
• sources/crp-jcm-2025 — Aleksova et al. 2025 J Clin Med review; four-phase structure detail, illness perception, RESILIENT trial, historical evolution from bedrest to early mobilisation